Related Experiment Videos
Experimental corticosteroid ocular hypertension in the rabbit
Summary
Repository betamethasone injections induced sustained ocular hypertension in rabbits, creating a reliable animal model for glaucoma drug testing. This model shows consistent results and responsiveness to glaucoma treatments.
Area of Science:
- Ophthalmology
- Pharmacology
- Veterinary Medicine
Background:
- Glaucoma is a leading cause of irreversible blindness worldwide.
- Animal models are crucial for understanding ocular hypertension and testing therapeutic interventions.
Purpose of the Study:
- To develop and validate a novel animal model for induced ocular hypertension.
- To assess the efficacy of repository betamethasone for creating a reproducible model of elevated intraocular pressure.
Main Methods:
- Rabbits received weekly subconjunctival injections of 4mg repository betamethasone over three weeks.
- Intraocular pressure (IOP) was monitored to assess the development and stability of ocular hypertension.
- Systemic toxicity and drug responsiveness were evaluated.
Main Results:
- A sustained increase in intraocular pressure (IOP) was achieved in 96% of treated rabbits.
- The induced ocular hypertension was constant, reproducible, and sensitive to antiglaucoma medications.
- Systemic toxic effects were minimal and observed in only a few animals.
Conclusions:
- Weekly repository betamethasone injections provide a highly effective and reproducible method for inducing ocular hypertension in rabbits.
- This validated animal model is suitable for preclinical evaluation of drugs targeting ocular hypertension and glaucoma.